Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cellgram-spine in Chronic Spinal Cord Injury
NCT01676441Phase 3Terminated
- Sponsor
- Pharmicell Co., Ltd.
- Start
- Aug 2008
- Primary completion
- Mar 2021
- Countries
- 1
01
Overview
A Phase 3 trial of Cellgram-Spine in spinal cord injury (SCI), sponsored by Pharmicell Co., Ltd.. Started Aug 2008; status: terminated.
02
Drugs
Cellgram-Spine
03
Conditions
spinal cord injury (SCI)
Beyond the preview
Go deeper on NCT01676441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01676441.